Skip to main content

Table 2 The demographic characteristics of the included studies

From: Dose intraarticular steroid injection increase the rate of infection in subsequent arthroplasty: grading the evidence through a meta-analysis

Study

Study design

Prosthesis

Steroid injection

Time from injection to surgery

Deep infection rate

Superficial infection rate

Follow-up period

    

Injected

Control

Injected

Control

Kaspar et al.

Retrospective cohort

THA

80 mg methylprednisolone

0.5-42.9 months

4/40

0/40

NR

NR

(9.9-86.2) months

Papavasiliou et al.

Retrospective cohort

TKA

NR

NR

3/54

0/90

12/54

10/90

1 year

McIntosh et al.

Retrospective cohort

THA

6–40 mg drug (not mentioned)

112 ± 81 days

3/224

1/224

11/224

8/224

NR

Sreekumar et al.

Retrospective cohort

THA

80 mg depomedrone

14 months

0/68

1/136

0/68

1/136

25-33 months

Desai et al.

Retrospective cohort

TKA

80 mg depomedrone

12 months

0/90

0/180

2/90

5/180

1-6 years

Haughton et al.

Retrospective cohort

THA

80 mg depomedrone or 40 mg triamcinolone

NR

4/254

14/1063

11/254

4/1063

NR

Meermans et al.

Retrospective cohort

THA

80 mg depomedrone +5–15 mg levobupivacaine

12 months

1/175

1/175

5/175

7/175

12-131 months

Croft et al.

Retrospective cohort

THA

40 mg depomedrol +4 ml 2% xylocaine

5.9 months

0/48

0/48

NR

NR

1.4-54.1 months

  1. THA, total hip arthroplasty; TKA, total knee arthroplasty; NR, not reported.